Two Sigma Advisers’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $26M | Buy |
|
|||||
|
2025
Q2 | $1.19M | Sell |
|
|||||
|
2025
Q1 | $40.9M | Sell |
|
|||||
|
2024
Q4 | $96.7M | Buy |
|
|||||
|
2024
Q3 | $76.7M | Buy |
|
|||||
|
2024
Q2 | $45.9M | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $5.27M | Sell |
|
|||||
|
2023
Q2 | $40.7M | Sell |
|
|||||
|
2023
Q1 | $58.3M | Buy |
|
|||||
|
2022
Q4 | $8M | Sell |
|
|||||
|
2022
Q3 | $20.6M | Sell |
|
|||||
|
2022
Q2 | $82.1M | Buy |
|
|||||
|
2022
Q1 | $131M | Sell |
|
|||||
|
2021
Q4 | $237M | Buy |
|
|||||
|
2021
Q3 | $3.1M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $1.53M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $54M | Buy |
|
|||||
|
2020
Q2 | $53M | Buy |
|
|||||
|
2020
Q1 | $28.5M | Buy |
|
|||||
|
2019
Q4 | $8.74M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $62.8M | Sell |
|
|||||
|
2019
Q1 | $65.7M | Sell |
|
|||||
|
2018
Q4 | $83.2M | Buy |
|
|||||
|
2018
Q3 | $6.24M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $260K | Sell |
|
|||||
|
2015
Q3 | $5.19M | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $689K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $697K | Buy |
|
|||||
|
2013
Q4 | $553K | Buy |
|
|||||
|
2013
Q3 | $268K | Buy |
|